Feinberg Consulting-Delray Beach

Located in Delray Beach, FL, Feinberg Consulting-Delray Beach operates within the FL regulatory framework as a licensed addiction-treatment provider. The specific care levels offered by Feinberg Consulting-Delray Beach should be confirmed directly with the admissions team. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Feinberg Consulting-Delray Beach

Care-level specifics for Feinberg Consulting-Delray Beach are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Feinberg Consulting-Delray Beach's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance posture: Payment and insurance specifics for Feinberg Consulting-Delray Beach are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Before you call

Pre-admission due-diligence for Feinberg Consulting-Delray Beach: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via FL behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Feinberg Consulting-Delray Beach offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.